Search

The newest edition of the thyroid cancer staging system has increased the age at diagnosis as a prognostic factor by a decade.

… Friday, March 1, 2019 The newest edition of the thyroid cancer staging system has increased the age at diagnosis as a prognostic factor by a decade. To understand the impact of this, and other recent changes, we staged patients using our extensive, prospectively collected database at Memorial Sloan Kettering

MSK investigators find that the presence of certain gene mutations in patients’ blood may mean they are more likely to get a secondary leukemia.

… Thursday, August 10, 2017 Summary MSK investigators have found that the presence of certain gene mutations in patients’ blood may mean they are more likely to get a secondary leukemia. The discovery may lead to new methods for determining who is at greatest risk. One of the most devastating things that

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

… Thursday, May 7, 2020 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Tsvi Gal Is Named MSK’s Head of Infrastructure Tsvi Gal Tsvi Gal Tsvi Gal has been appointed Head of Infrastructure of MSK. Mr. Gal assumed his role on April 28. Mr. Gal will lead the hospital

Memorial Sloan Kettering researchers helped to identify a key insight into what first goes wrong in the development of many leukemias.

… Thursday, June 30, 2011 Researchers at Memorial Sloan Kettering Cancer Center and New York University have discovered how a mutation in the gene known as TET2 contributes to the development of some leukemias . When a mutation in TET2 occurs, it enhances the function of blood stem cells in the bone marrow

Learn about Jakki Stout’s journey from MSK nurse practitioner to breast cancer patient and back to being an even more helpful and inspiring nurse at MSK.

… Monday, June 10, 2024 It’s easy to see that nurse practitioner Jaclyn Stout has a true passion for nursing. Jakki, as she’s called, is a skilled and compassionate caregiver who’s been at Memorial Sloan Kettering Cancer Center (MSK) for 10 years. She loves her work caring for surgery patients recovering

Risk-reducing salpingo-oophorectomy brings on early menopause and its attendant consequences. Researchers are exploring whether a less drastic surgical strategy can offer a safe and efficacious option.

… Friday, September 16, 2016 Since there is no effective screening test for ovarian cancer , the gold standard management approach for women who are at an increased risk for developing ovarian cancer is a risk-reducing salpingo-oophorectomy (RRSO), a surgical procedure to remove ovaries and fallopian tubes

Many women are confused by conflicting guidelines on breast screening. And the latest recommendations made by the USPSTF are adding to that confusion. MSK experts are available to answer questions and explain what MSK recommends and why it is not altering its guidelines. To schedule an interview with a member of MSK’s breast cancer leadership team, please contact Nicole McNamara at [email protected].

… Monday, January 11, 2016 Many women are confused by conflicting guidelines on breast screening. And the latest recommendations made by the USPSTF are adding to that confusion. MSK experts are available to answer questions and explain what MSK recommends and why it is not altering its guidelines. To schedule

Women and ethnic minorities are underrepresented in science. Memorial Sloan Kettering is working to change that.

… Friday, November 2, 2018 Edwin Kamau (NYU) and Laura González-Fajardo (University of Connecticut) Graduate students Edwin Kamau (NYU) and Laura González-Fajardo (University of Connecticut) Patrick Cherubin (University of Central Florida) and Michael Riley II (University of Florida) Graduate students

Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments.

… Thursday, June 6, 2024 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Andrea Cercek Named to the Inaugural 2024 TIME100 Health List Andrea Cercek Named to the Inaugural 2024 TIME100 Health List Andrea Cercek, MD , gastrointestinal oncologist, section

Learn how MSK specialists treat head and neck cancers using the most innovative approaches.

… Monday, May 1, 2017 Summary The chief of the Head and Neck Service describes Memorial Sloan Kettering’s expertise in diagnosing and treating these diseases. In recognition of Head and Neck Cancer Awareness Month, we asked Richard Wong, Chief of the Head and Neck Service, to discuss his team’s approach